Back to Transactions
Healthcare
2016

Riverside has sold Diatron to Stratec Biomedical

Client: The Riverside Company

Client Location: United States of America

Buyer: Stratec Biomedical AG

Buyer Location: Germany

Target: Diatron Group

Target Location: Hungary

Target Description: The Diatron Group is a hematology and clinical chemistry analyzer and reagent manufacturer.

Riverside Diatron Stratec 2016

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

I build trust with my clients through integrity and clear communication. Our clients value providing them with our market insight and expertise.

Ulrich Desl

Managing Director

Frankfurt

View More Transactions

Lincoln International advised Vance Street Capital Partners on its investment in Fumex

Industrials

Lincoln International advised Lutech, a portfolio company of Apax, on the acquisition of SAPIMSA and Netinex

Technology

Lincoln International advised Gilde Healthcare and Capital A Investment Partners on refinancing Tromp Medical

Healthcare

Lincoln International advised Ambienta on completing a single asset continuation vehicle transaction involving Wateralia

Industrials

Lincoln International advised Wynnchurch Capital on the sale of Gyptech to Fortress Investment Group

Industrials

Lincoln International advised OpenGate Capital on the sale of Premier Steel Doors and Frames, a division of Sargent & Greenleaf, to ASSA ABLOY Group

Building Products | Industrials

Lincoln International advised CIC Capital Partners on the sale of McClancy Foods & Flavors to NovaTaste, a portfolio company of PAI Partners

Consumer

Lincoln International advised Sentinel Capital Partners on the acquisition of NSI Industries from Odyssey Investment Partners

Business Services | Energy Transition, Power & Infrastructure | Industrials
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.